Results 61 to 70 of about 354 (138)

Personalization of Neoadjuvant Immunotherapy in High-Risk Resectable Melanoma and Utility of ctDNA as a Biomarker of Immunotherapy Response. [PDF]

Ann Surg Oncol
Lawless A, Effiom DN, Burbano A, Sharova T, Otten TJ, Basnet M, Spurr E, Shankar T, Crespo MC, Czapla JA, Bangrazi G, Emerick K, Sullivan RJ, Boland GM, Mooradian MJ, Cohen S.   +15 more
europepmc   +1 more source

Insights into inherited genetic variations and genetic ancestry of patients with high-risk melanoma. [PDF]

Melanoma Res
Tarhini AA, Khaksar MA, Chen Z, Lee SJ, Hodi FS, Li T, Monteiro AN, Streicher H, Sondak VK, Wang X, Kirkwood JM, Kanetsky PA.   +11 more
europepmc   +1 more source

A Pharmacokinetic and Pharmacodynamic Model of an IL-12 Anchored-Drug Conjugate for the Treatment of Solid Tumors. [PDF]

Mol Cancer Ther
Mistry HB, Hodson D, Battula S, Schmidt MM, Tighe R, Kaufman HL, Chassagnole C.   +6 more
europepmc   +1 more source

Ankyra

, 2012
Mihail Zahariade
core   +1 more source

Ankyra Tiyatrosu Zırhlı Hadrian Heykeli

, 2019
ZOROĞLU, Candemir
core   +2 more sources

Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report. [PDF]

Front Immunol
Habibzadeh P, Kulkarni A, Hurd D, Rose A, Bednarz D, Najjar YG, Kirkwood JM, Karunamurthy A, Davar D.   +8 more
europepmc   +1 more source

Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance. [PDF]

Nat Commun
Wright SJ, Zamora I, Parikh M, Yeramosu D, Rucevic M, Sade-Feldman M, LaSalle TJ, Blaum EM, Liu B, Bi L, Kang S, Blum SM, Nguyen N, Guess J, Kar A, Schneider AM, Lieb D, Woods E, Michaud W, Lawless AR, Sharova T, Cohen S, Kasumova G, Kim MS, Cheng LC, Villani AC, Park RJ, Jenkins RW, Klempner SJ, Sullivan RJ, Flaherty KT, Hacohen N, Mehta A, Boland GM.   +33 more
europepmc   +1 more source

Ankyra inerme Nov.sp., nouvelle espece de chlorococcales du lac Leman

, 1980
National ...
Reymond, O., Druart, J.C.
core  

UV irradiation drives lineage-specific MITF-mediated transcription of PD-L1 to confer immune tolerance to UV-mutated melanocytes. [PDF]

Immunity
Lo JA, Rachmin I, Flesher JL, Wu X, Kawakami A, Hejna M, Boozer JR, Nguyen N, King AD, Ji Y, Germana S, Kemeny LV, van der Sande AAJ, Cheng JB, Lotem M, Utne TR, Zhan Y, Roider EM, Mujahid N, Byrne EH, Singh S, Saidani M, Martineau S, Holic N, Baldeschi C, Martinat C, Freeman GJ, Hacohen N, Flaherty KT, Boland GM, Song JS, Sharpe AH, Demehri S, Yee C, Allouche J, Fisher DE.   +35 more
europepmc   +1 more source

Chemokine/cytokine-releasing biomaterials induce in situ tertiary lymphoid-like structures and enhance antitumor immunity. [PDF]

Proc Natl Acad Sci U S A
Falahat R, Mulé JJ.
europepmc   +1 more source